OBJECTIVE: To investigate the effects of b-(3,4-dihydroxyphenyl)lactic acid on oxidative stress stimulated by high glucose levels in human peritoneal mesothelial cells (HPMCs) in vitro. METHODS: HPMCs were incubated with 100 mol/l glucose followed by 0.625 -20 mg/ml b-(3,4-dihydroxyphenyl)lactic acid. Reactive oxygen species (ROS) were quantified by flow cytometry. Relative levels of fibronectin-1 (FN1), collagen-I a 1 (COL1A1), endothelin-1 (EDN1) and haem oxygenase-1 (HMOX1) mRNA and protein were quantified by real-time reverse transcription-polymerase chain reaction and Western blotting, respectively. Absolute levels of FN1 and COLIA1 were quantified by enzyme-linked immunosorbent assay. RESULTS: b-(3,4-Dihydroxyphenyl)lactic acid significantly decreased ROS levels, and EDN1 mRNA and protein levels, in dose-and timedependent manners. HMOX1 mRNA and protein levels were significantly increased by b-(3,4-dihydroxyphenyl)lactic acid in dose-dependent manners. COL1A1 and FN1 mRNA and protein levels were significantly decreased by b-(3,4dihydroxyphenyl)lactic acid in dose-and time-dependent manners. CONCLUSIONS: b-(3,4-Dihydroxyphenyl)lactic acid inhibited oxidative stress and reversed increases in FN1 and COLIA1 induced by high glucose levels in HPMCs. This may contribute to a protective role in peritoneal fibrosis.
Introduction
Continuous ambulatory peritoneal dialysis is an important and widely used renal replacement therapy, but loss of ultrafiltration caused by peritoneal fibrosis may result in treatment discontinuation. 1 Glucose is commonly used for maintaining osmotic pressure in peritoneal dialysis fluids. 2, 3 Longterm exposure to high glucose concentrations (≥ 100 mmol/l) may result in oxidative stress, which damages peritoneal mesothelial cells and may cause peritoneal fibrosis and ultrafiltration loss. 4 -6 The generation of excessive levels of reactive oxygen species H Zhang, J-W Wang, Y Xu et al. b-(3,4-Dihydroxyphenyl)lactic acid and HPMCs (ROS) results in oxidative stress. 7 Endothelin-1 (encoded by EDN1) is a major endogenous vasoconstrictor with an important role in oxidative stress. 8 The antioxidant enzyme haem oxygenase-1 (encoded by HMOX1) is induced by inflammatory mediators, oxidants and heavy metal ions, and has been shown to have antioxidant and antiinflammatory actions, to inhibit apoptosis and to improve the microcirculation. 9, 10 β-(3,4-Dihydroxyphenyl)lactic acid (salvianic acid A), is the main active ingredient of Salvia miltiorrhiza, a herb used in traditional Chinese medicine. The pharmacological action of β-(3,4dihydroxyphenyl)lactic acid is extensive and includes scavenging oxygen free radicals, improving ischaemia-reperfusion injury and inhibiting fibrosis. 11, 12 β-(3,4-Dihydroxyphenyl)lactic acid has been shown to affect downstream ROS signal transduction, reduce the hypertrophy of mesangial cells and the deposition of extracellular matrix, and prevent glomerular sclerosis. 13 The aim of the present study was to investigate the effect of β-(3,4-dihydroxyphenyl)lactic acid on mRNA and protein levels of ROS, EDN1, HMOX1 and extracellular matrix components (collagen-I α 1 [COLIA1] and fibronectin-1 [FN1]) induced by high glucose levels in human peritoneal mesothelial cells (HPMCs) in vitro. 
Materials and methods

CELL CULTURE
EXPERIMENTAL DESIGN
The HPMCs were seeded into six-well culture plates at a density of 5 × 10 5 cells/ml and cultured for 24 h. Cultures were then maintained in complete medium (control group; cultures terminated after 48 h) or complete medium with 100 mmol/l Dglucose (high glucose 14 ). After 48 h, the medium was removed and cultures were either terminated (glucose group) or incubated with fresh medium containing 0.625, 1.25, 2.5, 5 or 10 mg/l β-(3,4dihydroxyphenyl)lactic acid for 72 h (dosedependent experiments), or 10 mg/l β-(3,4dihydroxyphenyl)lactic acid for 12, 24, 48 or 72 h (time-dependent experiments). The maximum β-(3,4-dihydroxyphenyl)lactic acid concentration of 10 mg/l was determined from the cell proliferation assay described below. All experiments were performed in triplicate.
CELL VIABILITY ASSAY
A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) cell viability assay was performed to determine the highest concentration of β-(3,4-dihydroxyphenyl) lactic acid that HPMCs could tolerate. The cells were seeded into 96-well plates at a density of 1 × 10 4 cells/well and cultured for 3 days. β-(3,4-Dihydroxyphenyl)lactic acid was then added to the wells at final concentrations of 0.625, 1.25, 2.5, 5, 10 or 20 mg/l and the cells were cultured for a further 3 days. Control cultures contained no β-(3,4dihydroxyphenyl)lactic acid. A 20-µl aliquot of 5 mg/ml MTT solution was added to each well and incubated for 4 h. The culture medium was then centrifuged (1000 g for 5 min), the supernatant was discarded and 150 µl dimethylsulphoxide was added to each well, followed by shaking for 10 min to dissolve the crystals fully. Optical 
ROS FLOW CYTOMETRY
The HPMCs were incubated with 20 µmol/l 2′,7′-dichlorodihydrofluorescein diacetate probe (Sigma-Aldrich, St Louis, MO, USA) for 30 min at 37°C in the dark, digested with pancreatic enzymes (Amresco, Solon, OH, USA) and pelleted by centrifugation at 1200 g for 5 min. The cells were washed twice using 0.01 M phosphate buffered saline (PBS; pH 7.2) and the cell concentration was adjusted to 1 × 10 7 /ml in PBS containing 3% fetal bovine serum. Mean fluorescence intensity was determined using a Cytomics™ FC500 flow cytometer (Beckman Coulter, Brea, CA, USA) with CellQuest™ software (Beckman Coulter).
REAL-TIME QUANTITATIVE RT-PCR
Total RNA was extracted from 1 × 10 6 HPMCs using TRIzol ® reagent (Invitrogen, Carlsbad, CA, USA), according to the manufacturer's instructions and the method of Lu et al. 15 Firststrand cDNA was synthesized from 2-µg aliquots of total RNA by reverse transcription (RT) using the RevertAid™ First Strand cDNA Synthesis Kit (Fermentas Life Sciences, Glen Burnie, MD, USA). Real-time quantitative polymerase chain reaction (PCR) was performed using the Taq 2× PCR MasterMix kit (Tiangen Biochemical Technology, Beijing, China) with SYBR ® Green-based detection chemistry (Invitrogen), on a LightCycler ® Run 5.32 Real-Time PCR System (Roche, Berlin, Germany; 1 µl of cDNA was used in each PCR). Primer sequences for RT-PCR were FN1, COL1A1, HMOX1, EDN1 and ACTB (β-actin; internal control) and are given in Table 1 ; all primers were supplied by Sangon Biotech, Shanghai, China. The cycling programme involved preliminary denaturation at 94°C for 3 min, followed by 30 cycles of denaturation at 94°C for 30 s, annealing at the appropriate temperature (Table 1) for 30 s and elongation at 72°C for 30 s, followed by a final elongation step at 4°C for 7 min. Expression levels were quantified using the 2 -∆∆CT method, 16 with fold-induction of mRNA calculated relative to ACTB mRNA levels defined as 100%.
WESTERN BLOTTING
Protein was extracted from HPMCs by incubation in radioimmunoprecipitation H Zhang, J-W Wang, Y Xu et al. b-(3,4-Dihydroxyphenyl)lactic acid and HPMCs lysis buffer (50 mmol/l Tris-HCl, pH 7.4, 150 mmol/l sodium chloride, 1 mmol/l phenylmethanesulphonyl fluoride, 1 mmol/l ethylenediaminetetra-acetic, 5 µg/ml aprotinin, 5 µg/ml leupeptin, 1% Triton™ X-100 [Sigma-Aldrich], 1% sodium deoxycholate and 1% sodium dodecyl sulphate) for 60 min at 4°C. Lysates were centrifuged at 20 000 g for 15 min, the supernatant was collected and the protein concentration was determined by bicinchoninic acid protein assay (Boster, Wuhan, China), according to the manufacturer's instructions and the method of Huang et al. 17 Equal amounts of protein (typically 30 µg) were separated by 6% sodium dodecyl sulphate-polyacrylamide gel electrophoresis at 100 V for 70 min and electrophoretically transferred onto polyvinylidene fluoride membranes (Sigma-Aldrich) at 70 V for 60 min. Membranes were blocked with Tris-buffered saline-Tween 20 (TBST; 20 mmol/l Tris-HCl, 150 mmol/l sodium chloride and 0.1% Tween-20; pH 7.5) containing 5% nonfat dry milk at 4°C for 1 h and washed three times with TBST. The membranes were incubated with rabbit antihuman endothelin-1 monoclonal antibody (1 : 400 dilution), rabbit antihuman HMOX1 monoclonal antibody (1 : 400 dilution) and rabbit antihuman ACTB monoclonal antibody (1 : 600 dilution) (all from Beijing Biosynthesis Biotechnology, Beijing, China) overnight at 4°C. The primary antibodies were all diluted with TBST. Membranes were then washed three times with TBST, incubated with peroxidase conjugated goat antirabbit secondary antibody (1 : 2000 dilution in TBST; Beijing Biosynthesis Biotechnology) for 1 h at room temperature, and washed three times with TBST. Immunoreactivity was detected by enhanced chemiluminescence (Amersham ECL™ system; GE Healthcare Biosciences, Piscataway, NJ, USA) and visualized by 5 min exposure on film (Kodak, Hokkaido, Japan). Protein bands were quantified by scanning densitometry using Scion Image Software (Becton Dickinson Medical Devices, Suzhou, China), relative to ACTB as the internal control.
ENZYME-LINKED IMMUNOSORBENT ASSAY
Cultures were digested with trypsin (Sigma-Aldrich), the supernatant was centrifuged at 3000 g for 10 min at 4°C and cell debris was discarded. COLIA1 and FN1 were quantified using a double-antibody sandwich enzymelinked immunosorbent assay (R&D Systems, Minneapolis, MN, USA), according to the manufacturer's instructions. Optical density was measured using an Eclipse 80i fluorescence microscope (Nikon Instruments, Sendai, Japan), and the absorbance at 550 nm was subtracted from that at 450 nm. Results were quantified by reference to a standard curve.
STATISTICAL ANALYSES
Data were expressed as mean ± SD. Comparisons between multiple groups were performed using one-way analysis of variance. Pairwise comparisons between groups were analysed by Fisher's least significant difference test. Statistical evaluation of the data was carried out using SPSS ® version 17.0 (IBM SPSS Inc., New York, NY, USA) for Windows ® . A P-value < 0.05 was considered to be statistically significant.
Results
Dose-response assays indicated that the viability of HPMCs was significantly reduced by incubation with 20 mg/ml β-(3,4-dihydroxyphenyl)lactic acid for 12, 24, 48 or 72 h (P < 0.05; Fig. 1 ). Cell growth inhibition was 55.8% after 12 h and 76.2% after 72 h. Concentrations of β- (3,4- Incubation with D-glucose resulted in a significant increase in levels of COLIA1 and FN1 in culture media compared with control cultures (P < 0.01; Tables 2 and 3 ). This increase was reversed in dose-and timedependent manners by incubation with β-(3,4dihydroxyphenyl)lactic acid (P < 0.05 versus glucose-treated cultures; Tables 2 and 3 ).
The effects of β-(3,4-dihydroxyphenyl) lactic acid and D-glucose on EDN1 and HMOX1 mRNA levels are shown in Fig. 4 , and the effects on EDN1 and HMOX1 protein levels are shown in Fig. 5 . Incubation with glucose significantly increased EDN1 mRNA and protein levels compared with control cultures (P < 0.01). These glucose-induced increases were reversed by incubation with β-(3,4-dihydroxyphenyl)lactic acid in a dosebut not a time-dependent manner (P < 0.05 versus glucose-treated cultures). Levels of HMOX1 mRNA and protein were unaffected by incubation with glucose, but were 
Discussion
Oxidative stress plays an important role in glucose-induced peritoneal fibrosis. 18 In agreement with the literature, the present study found that ROS levels in HPMCs were significantly increased by incubation with a high concentration of glucose. 19 This increase in ROS levels was reversed by β-(3,4dihydroxyphenyl)lactic acid in dose-and Data presented as mean ± SD of three independent experiments, each performed in triplicate. a P < 0.01 versus control; b P < 0.05 and c P < 0.01 versus glucose; d P < 0.05 versus 0.625 mg/l; e P < 0.05 versus 1.25 mg/l; f P < 0.05 versus 2.5 mg/l; g P < 0.05 versus 5 mg/l; one-way analysis of variance and Fisher's least significant difference test. 12, 24, 48 or 72 h. Data presented as mean ± SD of three independent experiments, each performed in triplicate. a P < 0.01 versus control; b P < 0.05 and c P < 0.01 versus glucose; d P < 0.05 versus 0.625 mg/l; e P < 0.05 versus 1.25 mg/l; f P < 0.05 versus 2.5 mg/l; g P < 0.05 versus 5 mg/l; oneway analysis of variance and Fisher's least significant difference test time-dependent manners. The ROS act as intracellular signalling molecules, and may mediate the deposition of extracellular matrix and accelerate the development of glucose-induced peritoneal fibrosis. 20, 21 It is possible that β-(3,4-dihydroxyphenyl)lactic acid might inhibit the oxidative stress induced by high glucose concentrations in patients undergoing continuous ambulatory peritoneal dialysis. Peritoneal fibrosis, including glucoseinduced peritoneal fibrosis, is mediated by the formation of extracellular matrix. 22 Glucose treatment of HPMCs resulted in increased levels of COL1A1 and FN1 mRNA and protein in the present study, in agreement with the literature. 23 This increase in extracellular matrix components was reversed by β-(3,4-dihydroxyphenyl)lactic acid in the present study. High glucose concentrations in the peritoneal dialysate of patients undergoing continuous ambulatory peritoneal dialysis may, therefore, stimulate hyperplasia of the extracellular matrix via upregulation of COL1A1 and FN1, leading to the formation of peritoneal fibrosis in a process inhibited by β-(3,4-dihydroxyphenyl) lactic acid.
It is known that EDN1 is a proinflammatory cytokine with vasoconstrictive activity 24 that stimulates the synthesis of extracellular matrix and may play an important role in the process of organ fibrosis. 25 High glucose levels have been shown to increase EDN1 levels. 26 HMOX1 is a stress protein with catalytic activity that inhibits oxidative stress and reduces tissue damage induced by high glucose levels. 27 The present study showed that incubation with 100 mmol/l D-glucose significantly upregulated EDN1 mRNA and protein levels, but had no effect on HMOX1 levels. β-(3,4-Dihydroxyphenyl)lactic acid reversed the glucose-induced increase in EDN1 and increased HMOX1 levels in a dose-dependent manner, suggesting that peritoneal damage caused by high glucose may be partly mediated by endothelin. Damage to HPMCs occurring as a result of oxidative stress could, therefore, be ameliorated by the effects of β-(3,4-dihydroxyphenyl)lactic acid on EDN1 and HMOX1 levels.
In conclusion, the present study found that β- (3,4- Data presented as mean ± SD of three independent experiments, each performed in triplicate. Proteins were semiquantified by normalizing to β-actin. a P < 0.01 versus control; b P < 0.05 and c P < 0.01 versus glucose; d P < 0.05 versus 0.625 mg/l; e P < 0.05 versus 1.25 mg/l; f P < 0.05 versus 2.5 mg/l; g P < 0.05 versus 5 mg/l; one-way analysis of variance and Fisher's least significant difference test 
